Emibetuzumab plus ramucirumab: Simultaneous targeting of MET and VEGFR-2 in patients with advanced hepatocellular cancer in a phase 1b/2 study Meeting Abstract


Authors: Harding, J. J.; Bendell, J. C.; Fuchs, C. S.; Wang, X. J.; Wacheck, V.; Zhu, A. X.
Abstract Title: Emibetuzumab plus ramucirumab: Simultaneous targeting of MET and VEGFR-2 in patients with advanced hepatocellular cancer in a phase 1b/2 study
Meeting Title: 2016 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 4 Suppl.
Meeting Dates: 2016 Jan 21-23
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-02-01
Language: English
ACCESSION: WOS:000378109600293
PROVIDER: wos
DOI: 10.1200/jco.2016.34.4_suppl.300
Notes: Meeting Abstract: 300 -- Gastrointestinal Cancers Symposium -- JAN 21-23, 2016 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. James Joseph Harding
    250 Harding